Safety and Efficacy KollaGen II-xs: A 60-day Clinical Trial

被引：0

作者：

Bagatela, B. S. ^{[1
]}

Lopes, A. P. ^{[1
]}

Affonso Fonseca, F. L. ^{[1
]}

Morton, S. ^{[2
]}

Gu, J. ^{[3
]}

Perazzo, F. F. ^{[1
]}

机构：

[1] Univ Fed Sao Paulo, Dept Pharmaceut Sci, Diadema, SP, Brazil

[2] Mortec Sci, Dept Clin Med, Cambridge, ON, Canada

[3] Dept Res & Dev, Los Angeles, CA USA

来源：

WEST INDIAN MEDICAL JOURNAL | 2023年 / 70卷 / 01期

关键词：

Dietary supplement; efficacy; joint diseases; KollaGen II-xs; safety; KNEE OSTEOARTHRITIS;

D O I：

10.7727/wimj.2016.293

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To investigate the safety and efficacy of an avian sternal collagen type II hydrolysate, KollaGen II-xsT. Methods: A goniometer was used to measure the range of motion, a pain scale (Borg) was applied to subjectively percept the pain, and a properly calibrated sphygmomanometer was utilized to evaluate muscle strength. Results: The results indicated that the administration of 2000 mg/day of collagen type II hydrolysate for 60 days improved essential symptoms in individuals suffering from joint diseases, including the range of motion, general pain and muscle strength. No adverse effects were observed during the trial. Conclusion: The results support the view that collagen type II hydrolysate may be administered to patients suffering from joint diseases. These data encourage its use for patients suffering from degenerative joint diseases, including cartilage injuries, connective tissue disorders, polychondritis, joint defects, osteoarthritis and rheumatoid arthritis.

引用

页码：69 / 72

页数：4

共 14 条

[1] BOOTH FW, 1987, CLIN ORTHOP RELAT R, P15
[2] Borg G., 1998, BORGS PERCEIVED EXER
[3] Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
Clegg, DO
Reda, DJ
Harris, CL
Klein, MA
O'Dell, JR
Hooper, MM
Bradley, JD
Bingham, CO
Weisman, MH
Jackson, CG
Lane, NE
Cush, JJ
Moreland, LW
Schumacher, HR
Oddis, CV
Wolfe, F
Molitor, JA
Yocum, DE
Schnitzer, TJ
Furst, DE
Sawitzke, AD
Shi, H
Brandt, KD
Moskowitz, RW
Williams, HJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08) : 795 - 808
[4] Flechsenhar K, 2005, Orthop Praxis, V9, P486
[5] Static postural sway, proprioception, and maximal voluntary quadriceps contraction in patients with knee osteoarthritis and normal control subjects
Hassan, BS
Mockett, S
Doherty, M
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (06) : 612 - 618
[6] THE MODIFIED SPHYGMOMANOMETER - AN INSTRUMENT TO MEASURE MUSCLE STRENGTH - A VALIDATION-STUDY
HELEWA, A
GOLDSMITH, CH
SMYTHE, HA
[J]. JOURNAL OF CHRONIC DISEASES, 1981, 34 (07): : 353 - 361
[7] LEQUESNE MG, 1987, SCAND J RHEUMATOL, P85
[8] Quadriceps weakness in knee osteoarthritis: the effect on pain and disability
O'Reilly, SC
Jones, A
Muir, KR
Doherty, M
[J]. ANNALS OF THE RHEUMATIC DISEASES, 1998, 57 (10) : 588 - 594
[9] Oral administration of 14C labeled gelatin hydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL)
Oesser, S
Adam, M
Babel, W
Seifert, J
[J]. JOURNAL OF NUTRITION, 1999, 129 (10) : 1891 - 1895
[10] Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagen
Oesser, S
Seifert, J
[J]. CELL AND TISSUE RESEARCH, 2003, 311 (03) : 393 - 399

← 1 2 →